The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription ...
With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
Data and analytics company GlobalData says the hydrogen economy has recently experienced some hiccups in its growth story, noting that demand for this commodity is not rising at the pace it was ...
Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback